BR112018008181A2 - baclofen intravenoso e métodos de tratamento - Google Patents
baclofen intravenoso e métodos de tratamentoInfo
- Publication number
- BR112018008181A2 BR112018008181A2 BR112018008181A BR112018008181A BR112018008181A2 BR 112018008181 A2 BR112018008181 A2 BR 112018008181A2 BR 112018008181 A BR112018008181 A BR 112018008181A BR 112018008181 A BR112018008181 A BR 112018008181A BR 112018008181 A2 BR112018008181 A2 BR 112018008181A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment methods
- intravenous baclofen
- intravenous
- baclofen
- dosage
- Prior art date
Links
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000794 baclofen Drugs 0.000 title abstract 3
- 238000001990 intravenous administration Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562244537P | 2015-10-21 | 2015-10-21 | |
| PCT/US2016/058311 WO2017070614A1 (en) | 2015-10-21 | 2016-10-21 | Intravenous baclofen and methods of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018008181A2 true BR112018008181A2 (pt) | 2018-11-06 |
Family
ID=58558177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018008181A BR112018008181A2 (pt) | 2015-10-21 | 2016-10-21 | baclofen intravenoso e métodos de tratamento |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20170112789A1 (ja) |
| EP (1) | EP3347004A4 (ja) |
| JP (1) | JP2018531271A (ja) |
| AU (1) | AU2016342046A1 (ja) |
| BR (1) | BR112018008181A2 (ja) |
| CA (1) | CA3001709A1 (ja) |
| MX (1) | MX2018004656A (ja) |
| RU (1) | RU2018118617A (ja) |
| WO (1) | WO2017070614A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4019016A1 (en) * | 2020-12-24 | 2022-06-29 | Allaysis, LLC | Methods of administering intravenous baclofen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH26730A (en) * | 1988-12-30 | 1992-09-28 | Ciba Geigy Ag | Coated adhesive tablets |
| WO2016115504A1 (en) * | 2015-01-15 | 2016-07-21 | Allaysis, Llc | Intravenous baclofen formulations and treatment methods |
-
2016
- 2016-10-21 US US15/331,757 patent/US20170112789A1/en not_active Abandoned
- 2016-10-21 WO PCT/US2016/058311 patent/WO2017070614A1/en active Application Filing
- 2016-10-21 JP JP2018520503A patent/JP2018531271A/ja active Pending
- 2016-10-21 AU AU2016342046A patent/AU2016342046A1/en not_active Abandoned
- 2016-10-21 RU RU2018118617A patent/RU2018118617A/ru not_active Application Discontinuation
- 2016-10-21 MX MX2018004656A patent/MX2018004656A/es unknown
- 2016-10-21 CA CA3001709A patent/CA3001709A1/en not_active Abandoned
- 2016-10-21 EP EP16858394.6A patent/EP3347004A4/en not_active Withdrawn
- 2016-10-21 BR BR112018008181A patent/BR112018008181A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018531271A (ja) | 2018-10-25 |
| US20170112789A1 (en) | 2017-04-27 |
| CA3001709A1 (en) | 2017-04-27 |
| AU2016342046A1 (en) | 2018-05-17 |
| MX2018004656A (es) | 2019-01-10 |
| EP3347004A1 (en) | 2018-07-18 |
| RU2018118617A (ru) | 2019-11-21 |
| WO2017070614A1 (en) | 2017-04-27 |
| EP3347004A4 (en) | 2019-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2016000224A (es) | Tratamientos combinados con anticuerpos anti-cd38 | |
| PH12016501978A1 (en) | Treatment of nafld and nash | |
| MX2017001587A (es) | Terapia de combinacion para tratar un paramixovirus. | |
| BR112017011900A2 (pt) | tratamento de ataques com fosfatase alcalina recombinante | |
| MX2015014500A (es) | Terapia de combinacion de anticuerpos contra csf-1r y agonista de tlr9. | |
| CL2016002971A1 (es) | Combinación. | |
| BR112015019995A2 (pt) | Combinação terapêutica envolvendo anticorpos contra claudina 18.2 para tratamento de câncer | |
| MX2016002645A (es) | Tratamiento combinado para tratar el glioblastoma. | |
| BR112019007613A2 (pt) | terapia de combinação para inibição de c3 | |
| BR112018007356A2 (pt) | métodos de produção de formas fucosiladas e não fucosiladas de uma proteína | |
| BR112017018620A2 (pt) | método de administração de tradipitanto, e, tradipitanto. | |
| PH12015501071A1 (en) | Combination therapy of anti-her3 antibodies | |
| ECSP17015977A (es) | Terapia de combinacion | |
| EP3111732A4 (en) | Linear accelerator system with stable interleaved and intermittent pulsing | |
| MX2016011160A (es) | Tratamiento de afecciones asociadas con la hiperinsulinemia. | |
| BR112018003178A2 (pt) | absorvente feminino com braçadeiras de barreira | |
| BR112019004783A2 (pt) | variantes de alfa-glicosidase ácida e usos das mesmas | |
| EA201790312A1 (ru) | Комбинации лекарственных средств для лечения множественной миеломы | |
| MX2015010077A (es) | Terapia de combinacion para el tratamiento de neumonia nosocomial. | |
| BR112019005539A2 (pt) | métodos de tratamento de lesão renal aguda | |
| MX2017012553A (es) | Compuestos espirociclicos. | |
| BR112019005040A2 (pt) | aplicação de pridopidina para tratamento de síndrome de rett | |
| BR112016012248A2 (pt) | método de tratamento de nefropatia | |
| MX2016009597A (es) | Terapias para el influenzavirus a subtipo h7n9. | |
| CL2016000396A1 (es) | Tratamiento contra el mieloma múltiple |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |